This inventor holds 1 USPTO granted patent. Top assignees: University of Washington, Yeda Research and Develpment & Co. Ltd. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020
Title: Per Jr Greisen: Innovator in Phosphotriesterase Research
Introduction
Per Jr Greisen is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biochemistry, particularly in the development of polypeptides that can mitigate the effects of organophosphate exposure. His innovative work has implications for both medical and environmental safety.
Latest Patents
Greisen holds a patent for "Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage." This patent describes a genetically modified polypeptide that exhibits at least twice the catalytic efficiency for a V-type nerve agent compared to the standard phosphotriesterase sequence. The implications of this invention are profound, as it offers potential solutions for treating individuals affected by organophosphate toxicity.
Career Highlights
Throughout his career, Greisen has worked with esteemed institutions such as the University of Washington and Yeda Research and Development Co. Ltd. His research has focused on enhancing the efficacy of enzymes that can break down harmful substances, showcasing his commitment to advancing scientific knowledge and public health.
Collaborations
Greisen has collaborated with notable colleagues in his field, including Gustav Oberdorfer and Izhack Cherny. These partnerships have contributed to the depth and breadth of his research, fostering an environment of innovation and discovery.
Conclusion
Per Jr Greisen's work in the field of phosphotriesterase research exemplifies the impact of innovative thinking on public health and safety. His contributions continue to pave the way for advancements in biochemistry and environmental protection.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile